NASDAQ:IDXX

IDEXX Laboratories (IDXX)

546.42
+7.06 (1.31%)
as of Jul 24, 2026, 6:48:31 pm Market Open.
14 watching
0
Investor Insights
star iconJul 24, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

IDEXX Laboratories (IDXX) has recently demonstrated impressive growth, with a topline growth acceleration to approximately 15%, a marked improvement from the mid-to-high single digits observed in previous quarters. Following the announcement of these solid numbers, the company's share price surged over 20% in a single day, reflecting strong investor confidence. Despite this positive momentum, current trading levels place IDXX at approximately 50 times Forward P/E, which raises concerns about its valuation given that future growth is projected at only 8%-9%. While investors are encouraged to hold their positions, there is a prevailing sentiment that it’s not an optimal time to add to investments in IDXX and that patience may yield better opportunities in the future.

consensus icon
Consensus
Hold
valuation icon
Valuation
Overvalued
review icon
Similar
WBA, WBA
BUY ON WEAKNESS
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

IDXX recently reported solid numbers as its topline growth accelerated to around 15% compared to previous quarters of around mid-to-high single digits. The company reacted favourably to the news as its share price jumped more than 20% in a single day. We think IDXX’s investment thesis as a high-quality, capital-light compounder in the pet healthcare industry remains intact. That being said, IDXX is now trading at around 50x Forward P/E, and growth over the next few years is expected to be around 8%-9%. We are comfortable holding the position here, but we don’t think it is too attractive to add at the current levels. We would prefer to be patient and wait for another opportunity to add to the name.
Unlock Premium - Try 5i Free   

BUY

Is up 26% today. He expects it to top $706.

DON'T BUY

They're too inconsistent.

WEAK BUY

Makes diagnostic equipment for veterinarians. It has sold off hard, because pet plays are seen as Covid stocks, but has been recovering (reported a beat in early August), but shares have been cold since that report.

HOLD
They offer healthcare to animals and pets. Stay with it. He believes in how they serve pets.
DON'T BUY
Jan.6-April 27 is seasonality. Healthcare stocks have made huge gains, but not IDXX. It's rolling over now and resisting its 200-day moving average. He's concerned. It's underperforming.
BUY
These lab stocks are news-driven and could drop on a negative headline. Each time it pulled back, it bounced back higher. The chart looks good here and he would buy.
Showing 1 to 7 of 7 entries
  • «
  • 1
  • »

IDEXX Laboratories (IDXX) Frequently Asked Questions

What is IDEXX Laboratories stock symbol?

IDEXX Laboratories is a American stock, trading under the symbol IDXX (previously IDXX-Q on Stockchase) on the NASDAQ (IDXX). It is usually referred to as NASDAQ:IDXX or IDXX

Is IDEXX Laboratories a buy or a sell?

In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on IDXX (previously IDXX-Q on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY on WEAKNESS. Read the latest stock experts' ratings for IDEXX Laboratories.

Is IDEXX Laboratories a good investment or a top pick?

IDEXX Laboratories was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for IDEXX Laboratories.

Why is IDEXX Laboratories stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for IDEXX Laboratories.

Is IDEXX Laboratories worth watching?

IDEXX Laboratories is followed by 14 investors on Stockchase and is a trending stock that is worth watching.

What is IDEXX Laboratories stock price?

On 2026-07-24, IDEXX Laboratories (IDXX) stock closed at a price of $546.42.